Clovis: Q4 Earnings Snapshot

February 23, 2022 GMT

BOULDER, Colo. (AP) _ Clovis Oncology Inc. (CLVS) on Wednesday reported a loss of $64.4 million in its fourth quarter.

The Boulder, Colorado-based company said it had a loss of 50 cents per share. Losses, adjusted for non-recurring costs, came to 49 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

The biopharmaceutical company posted revenue of $36 million in the period.

For the year, the company reported that its loss narrowed to $264.5 million, or $2.29 per share. Revenue was reported as $148.8 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CLVS at